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ABSTRACT
We report the case of a patient with congenital toxoplasmosis and 
submacular hemorrhage caused by a neovascular membrane who 
underwent an intravitreal injection of C3F8 and bevacizumab, and had 
a good visual recovery.
Keywords: Toxoplasmosis, congenital/etiology; Retinal hemorrhage/
etiology; Intravitreal injections/adverse effects; Retinal neovascularization/
complications; Angiogenesis inhibitors; Tomography, optical coherence; 
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RESUMO
Relatamos o caso de uma paciente com toxoplasmose congênita e 
hemorragia submacular por uma membrana neovascular submetida 
à injeção intravítrea de C3F8 e bevacizumabe, com boa recuperação 
visual.
Descritores: Toxoplasmose congênita/etiologia; Hemorragia retiniana/
etiologia; Injeções intravítreas/efeitos adversos; Neovascularização 
retiniana/complicações; Inibidores da angiogênese; Tomografia de 
coerência óptica; Relatos de casos
INTRODUCTION
The retinochoroiditis is the most common manifestation 
of congenital toxoplasmosis that is bilateral in 50 to 80% 
of cases. This inflammation could also compromise the 
retinal vascular system and the formation of subretinal 
neovascular membrane, which could be seen in the edge 
of the lesion or distant from the edge with nourishing 
arteries arising from the scar.(1)
We report a case of patient with congenital toxoplasmosis 
caused by subretinial neovascular membrane with a 
submacular hemorrhage that, although infrequent, could 
promote important consequences because of the visual 
acuity reduction. Despite this fact, it could be treated 
with possibility of recovering. 
CASE REPORT
LSE, an 18-year-old student woman was admitted to 
the Hospital das Clínicas da Faculdade de Medicina da 
Universidade de São Paulo on February 2010, with low 
visual acuity for 1 week. The patient was diagnosed 
with ocular congenital toxoplasmosis by the age 15 
years old. 
An ophthalmologic exam performed at admission 
showed corrected visual acuity with counting finger 
from 1m in the right eye and hand motion in the left 
eye. The visual acuity in the left eye of the patient was 
20/20 without correction, which happened before she 
develops the reported episode according to information 
collected from the medical record. In order to register 
and support the diagnosis a retinography and an 
angiofluoresceinography were conducted (Figure 1). 
On February 18, 2010 the patient, in face-down position, 
received an intravitreal injection of 0.3mL of C3F8 in 
left eye. 
One day after the procedure the patient was 
presenting vision of 20/50 and inferior displacement of 
submacular hemorrhage (Figure 2). 
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Figure 1. Scar area with submacular hemorrhage in the left eye
Figure 2. First day after intravitreal injection of C3F8
Figure 3. One week after intravitreal injection of C3F8
Figure 4. One week after intravitreal injection of bevacizumab
Figure 5. Six months after intravitreal injection of bevacizumab
On August 25, 2010 a reduction of visual acuity 
to 20/200 was seen. The funduscopy revealed partial 
absorption of hemorrhage but with macular edema 
(Figure 3). Based on this clinical feature, on March 1, 
2010 an intravitreal bevacizumab injection was conducted. 
A week after this procedure the patient showed 
visual acuity of 20/20 in the left eye. The retinography 
showed a higher reduction of submacular hemorrhage 
and and hyperfluorescence due to impregnation of 
neovascular membrane without significant leakage. 
The optical coherence tomography found a neovascular 
membrane in front of pigment epithelium without 
significant intraretinal edema (Figure 4). 
After 6 months of follow-up, the visual acuity of 
20/20 in the left eye was maintained and no signs of 
membrane activity were found in fundoscopy, fluorescein 
angiography and optical coherence tomography (Figure 5).
DISCUSSION
Choroidal neovascular membrane is a rare complication 
of toxoplasmic chorioretinitis related to the production 
of vascular endothelial growing factor.(2)
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Studies that analyzed the causes of submacular 
hemorrhage found that those secondary to age-related 
macular degeneration (ARMD) present a worse visual 
prognosis than those secondary to trauma, macroaneurysm 
or congenital toxoplasmosis.(3) 
The treatment with low doses (18 to 50mg) of 
intravitreal tissue plasminogen activator and 0.3mL 
perfluoropropane followed by face-down position for 3 
days, present good results in patients with submacular 
hemorrhage secondary to ARMD.(4)
There are studies showing that children with 
neovascular membrane had better visual recovery than 
adults.(5)
A study with intravitreal injection of C3F8 and 
bevacizumab, the same injection used in our case, 
reported good visual recovery, probably because it 
removed the blood in macular region, which decreases 
the toxicity to photoreceptors.(6) The blood in macular 
region that come in contact with photoreceptors leads 
to edema of these receptors after 1 hour of bleeding 
and causes the destruction of external nuclear layer in 
2 weeks due to toxic effects of iron in the hemoglobin.(7) 
The objective of bevacizumab use is to reduce the 
vascular permeability that provokes an involution of 
subretinal neovascular membrane.(6) 
Other method reported in the literature for treatment 
of submacular hemorrhage secondary to congenital 
toxoplasmosis, which presented good results, was the 
photodynamic therapy.(8)
CONCLUSION
Although unusual, the submacular hemorrhage must 
be considered in patients with congenital toxoplasmosis 
who already had scars and subretinal membrane with 
good visual acuity that evolved with sudden decrease of 
vision. The lack of studies comparing natural evolution 
of neovascular membrane secondary to toxoplasmosis 
scar in the eye enables to state that the best treatment 
for retinochoroiditis would be the one reported in this 
case especially for young patients with normal vision in 
only one eye. 
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